Eli Lilly and Company "Very Much Opposed" to Merger: CEO
BEIJING (Reuters) - Drugmaker Eli Lilly (NYSE:LLY - News), which faces plunging sales due to competition and lapsing patents, will not merge with another peer to ride out any rough times ahead, chief executive John Lechleitr said on Saturday.